Notably, exenatide has demonstrated the ability to reduce intracranial pressure without significant changes in body weight, presenting a novel therapeutic approach for managing headaches linked to intracranial hypertension [99]
Oral tablets: Rybelsus, taken once daily
Your prescriber will gradually increase your dosage each week until you reach the target dose of 3 mg daily
Archived from the original on 2 October 2017
van der Klaauw AA, Croizier S, Mendes de Oliveira E, Stadler LKJ, Park S, Kong Y, Banton MC, Tandon P, Hendricks AE, Keogh JM, Riley SE, Papadia S, Henning E, Bounds R, Bochukova EG, Mistry V, O'Rahilly S, Simerly RB, Minchin JEN, Barroso I, Jones EY, Bouret SG, Farooqi IS